Quantitative Approaches to Drug Discovery and Precision Medicine: A Joint QBI-Prime Symposium

Co-organized by Drs. Nevan Krogan, Brian Shoichet and Molly Shoichet, the Quantitative Biosciences Institute (QBI) at the University of California, Francisco and PRiME Next-Generation Precision Medicine at the University of Toronto present a joint symposium on "Quantitative Approaches to Drug Discovery and Precision Medicine" in San Francisco on November 8, 2024.

QBI seeks transformative results in biomedicine by supporting fundamental quantitative research in the biological sciences through significant collaborative efforts. PRiME brings together world-class scientists, engineers and innovators at the University of Toronto to tackle unmet needs in drug discovery, diagnostics and disease biology.

The symposium aims to build collaborative relationships between scientists from both institutions. The intersection of drug discovery and personalized medicine with quantitative biology, machine learning and artificial intelligence opens new opportunities for discovery and training, ultimately leading to translation and new therapeutics for improved human health. The event will highlight cutting edge research with a view towards a partnership between QBI and PRiME.

Host or Publisher QBI